U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06850623) titled 'Acoustic Cluster Therapy (ACT) with Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer' on Jan. 15.
Brief Summary: The purpose of the study is to assess the efficacy and safety of Acoustic Cluster Therapy (ACT) when given in addition to chemotherapy for treatment of Locally Advanced Pancreatic Cancer.
Study Start Date: March 01
Study Type: INTERVENTIONAL
Condition:
Locally Advanced Pancreatic Adenocarcinoma
Intervention:
COMBINATION_PRODUCT: Acoustic Cluster Therapy
Drug: PS101; Device: Ultrasound
DRUG: Modified FOLFIRINOX
Chemotherapy
Recruitment Status: NOT_YET_RECRUITING
Sponsor: EXACT Therapeutics AS...